# A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

> **NCT06752668** · PHASE2 · RECRUITING · sponsor: **Centessa Pharmaceuticals (UK) Limited** · enrollment: 248 (estimated)

## Conditions studied

- Narcolepsy Type 1
- Narcolepsy Type 2
- Idiopathic Hypersomnia

## Interventions

- **DRUG:** ORX750
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06752668
- **Lead sponsor:** Centessa Pharmaceuticals (UK) Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-23
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06752668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06752668, "A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06752668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*